Ee Wee - Haw ParLimited CEO

CEO

Mr. Wee Ee Lim is President, Chief Executive Officer, Executive Director of Haw Par Corporation Ltd. He joined the Group in 1986 and became President CEO of Haw Par Corporation Limited in 2003. He was appointed to the Board on 23 March 1994 and was last reelected on 28 April 2015. Mr Wee is a member of the Investment Committee. He was closely involved in the management and growth of the Group over the last 30 years. He is a Director and Deputy Chairman of UOL Group Limited. He is a Director of United Industrial Corporation Limited and Wee Foundation. He was previously a Director of Pan Pacific Hotels Group Limited, Singapore Land Limited and Hua Han Health Industry Holdings Limited . He holds a Bachelor of Arts degree from Clark University, USA. since 2003.
Age 62
Tenure 21 years
Phone65 6337 9102
Webhttps://www.hawpar.com

Haw ParLimited Management Efficiency

Haw ParLimited's management efficiency ratios could be used to measure how well Haw ParLimited manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 12.92 M in total debt with debt to equity ratio (D/E) of 0.0, which may suggest the company is not taking enough advantage from borrowing. Haw ParLimited has a current ratio of 7.37, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Haw ParLimited until it has trouble settling it off, either with new capital or with free cash flow. So, Haw ParLimited's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Haw ParLimited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Haw to invest in growth at high rates of return. When we think about Haw ParLimited's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 13 records

CEO Age

Joseph JimenezNovartis AG ADR
58
Richard SaynorNovartis AG ADR
57
Paul HudsonNovartis AG ADR
51
Brian McNamaraGlaxoSmithKline PLC ADR
49
Andrew WittyGlaxoSmithKline PLC ADR
50
Chris IlsleyNovartis AG ADR
N/A
Francesco BalestrieriNovartis AG ADR
N/A
Emma WalmsleyGlaxoSmithKline PLC ADR
55
Elizabeth BarrettNovartis AG ADR
56
Bruno StriginiNovartis AG ADR
N/A
Michael BallNovartis AG ADR
62
Deborah WaterhouseGlaxoSmithKline PLC ADR
N/A
Jacob NaardenEli Lilly and
39
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company was incorporated in 1969 and is based in Singapore. Haw Par operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. Haw Par [HAWPF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Haw ParLimited Leadership Team

Elected by the shareholders, the Haw ParLimited's board of directors comprises two types of representatives: Haw ParLimited inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haw. The board's role is to monitor Haw ParLimited's management team and ensure that shareholders' interests are well served. Haw ParLimited's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haw ParLimited's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sat Khattar, Independent Director
Siew Shiu, Acting Group Internal Audit Manager
Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd
Swee Sim, Non-Executive Independent Director
Cho Wee, Non-Executive, Non Independent Chairman of the Board
Chua Keeth, Deputy General Manager - Marketing of Haw Par Healthcare Limited
Wah Ng, Deputy General Manager-Manufacturing of Healthcare
Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited
Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare
Brian Loo, Group Mang
Peter Chew, Deputy General Manager of Underwater World Singapore Pte Ltd
Kia Chew, Non-Executive Independent Director
Choon Chew, Non-Executive Independent Director
Tang Lee, Mang Communications
Tang Chow, Human Director
Anthony Chang, Curator of Underwater World Singapore Pte Ltd
Suan Lee, Non-Executive Independent Director
Kun Chiew, Group Sec
Ah Han, Executive Director, Member of Investment Committee, General Manager of Haw Par Healthcare Limited and Director of Haw Par Healthcare Limited
Hiang Gn, Non-Executive Independent Director
Seok Lim, CFO and Company Secretary
Sien Tarn, General Manager - Corporate Development & Property Division
Sung Whang, General Manager of Underwater World Pattaya Ltd
Soo Hwang, Non-Executive Independent Director
Bee Goh, Director & General Manager - Manufacturing of Haw Par Healthcare Limited
Say Chow, Group Finance Controller
Jasmin Hong, Deputy General Manager - Marketing of Haw Par Healthcare Limited
Kay Lee, Company Secretary
EeChao Wee, Non-Executive Deputy Chairman of the Board

Haw Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haw ParLimited a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Haw ParLimited in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Haw ParLimited's short interest history, or implied volatility extrapolated from Haw ParLimited options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Tools for Haw Pink Sheet

When running Haw ParLimited's price analysis, check to measure Haw ParLimited's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw ParLimited is operating at the current time. Most of Haw ParLimited's value examination focuses on studying past and present price action to predict the probability of Haw ParLimited's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw ParLimited's price. Additionally, you may evaluate how the addition of Haw ParLimited to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Money Managers
Screen money managers from public funds and ETFs managed around the world